InsidersTradesSigma
Total declarations
Companies
▲ Purchases (14 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
14
Disclosed sells
2
T+90 hit rate
50%
T+90 mean return
+13.3%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by MOTT DAVID M. Director active across 5 companies, notably Epizyme, Inc.. In total, 42 disclosures have been recorded. Split: 14 buys · 2 sells. Total volume traded: €8.5m. Activity tracked since 11 June 2021. The latest transaction was disclosed on 15 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations42 total
20,282 sharesCommon StockSEC:0001219871-26-000003:0
26,455 sharesCommon StockSEC:0001219871-26-000003:1
100,000 shares@ US$3.29124.9% of flowCommon StockSEC:0001628280-25-026573:0
Ideal exit: 9 Feb 2026 (T+270)
381,377 shares@ US$4.22423.9% of flowCommon StockSEC:0001628280-25-022357:0
Ideal exit: 27 Jan 2026 (T+270)
77,729 shares@ US$5.00126.2% of flowCommon StockSEC:0001628280-25-008296:0
Ideal exit: 21 Nov 2025 (T+270)
199,000 shares@ US$4.988316.0% of flowCommon StockSEC:0001628280-25-002226:0
Ideal exit: 18 Oct 2025 (T+270)
100,000 shares@ US$0.550.9% of flowCommon StockSEC:0001628280-24-052533:0
213,300 shares@ US$4.672216.2% of flowCommon StockSEC:0001628280-24-052363:0
Ideal exit: 15 Sept 2025 (T+270)
215,868 shares@ US$4.616715.7% of flowCommon StockSEC:0001628280-24-047919:0
Ideal exit: 10 Aug 2025 (T+270)
17,322 shares0Common StockSEC:0001628280-24-028594:0
6,670 shares0Common StockSEC:0001593968-24-000861:0
8,810 shares0Common StockSEC:0001104659-24-001358:0
15,873 shares0Common StockSEC:0001104659-23-106831:0
6,079 shares0Common StockSEC:0001104659-23-078749:0
25,510 shares0Common StockSEC:0001628280-23-022554:0
3,100 sharesCommon StockSEC:0001209191-23-036757:0
14,467 shares0Common StockSEC:0001104659-23-070358:0
4,866 shares0Common StockSEC:0001104659-23-042242:0
567,000 shares@ US$1.764816.1% of flowCommon StockSEC:0001567619-22-020554:0
Ideal exit: 14 Aug 2023 (T+270)
215,494 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028869:0
16,156 shares@ US$1.4713.6% of flowCommon Stock, par value $0.0001SEC:0000899243-22-025018:0
700 sharesCommon StockSEC:0001209191-22-038596:0
182,481 shares0Common StockSEC:0001567619-22-013204:0
8,994 shares0Common Stock, par value $0.0001SEC:0000899243-22-018829:0
20,653 shares@ US$1.1514.8% of flowCommon Stock, par value $0.0001SEC:0000899243-22-013153:0
25 of 42 declarations
About MOTT DAVID M
David M. Mott is an executive at Epizyme, Inc.
